Laurie McLouth
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Laurie McLouth sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,751 sponsors by registered trial count).
Laurie McLouth: 3 sponsored US clinical trials, 1 recruiting.
Laurie McLouth sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Lung Cancer, with 1 trials.
Upper-quartile sponsor footprint
Laurie McLouth sits in the upper quartile of the sponsor corpus (#3,661 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
3 total, page 1 of 1
Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment
NCT06047301
Piloting 'mPal,' a Multilevel Strategy for Palliative Care Implementation
NCT05270395
Piloting Pathways With Lung Cancer Patients
NCT04161157
Therapeutic Areas
What is open in the Laurie McLouth pipeline
1 recruiting of 3 indexed (33% open); 2 completed (67%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Lung Cancer (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.